SEC Form 4 · accession 0000891293-15-000045
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP, Global Medical Affairs · Director
Period of report
Sep 25, 2015
Accepted (ET)
Sep 25, 2015 · 6:51 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 25, 2015 | S | 1,300 | $1.63 | D | 1,465,550 | D | |
| Common Stock | Sep 25, 2015 | S | 400 | $1.6325 | D | 1,465,150 | D | |
| Common Stock | Sep 25, 2015 | S | 100 | $1.635 | D | 1,465,050 | D | |
| Common Stock | Sep 25, 2015 | S | 13,200 | $1.64 | D | 1,451,850 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a Rule 10b5-1 trading plan.